Library
bvp.capitalCrawled Oct 25, 2026
Product
6 pages- Chemtrix ~ BVP/portfolio/chemtrix
Microreactor technology for efficient and safe chemical synthesis.
- Circularise ~ BVP/portfolio/circularise
End-to-end traceability and secure data exchange for industrial supply chains.
- Corporis medical ~ BVP/portfolio/corporis-medical
Surgical devices improving safety and decision-making in minimally invasive surgery.
- EnzyPep ~ BVP/portfolio/enzypep
Enzymatic peptide synthesis technology for pharmaceutical manufacturing.
Blog
6 pages- Articles Archive ~ BVP/article
- AVL Motion: “Aiming to solve the major challenge: labour shortages!” ~ BVP/article/avl-motio-deep-dive
Arno van Lankveld, founder of AVL Motion, draws on his family’s asparagus farming to address challenges in the industry.
- BVP 2023 Impact Report now available! ~ BVP/article/bvp-2023-impact-report-now-available
Brightlands Venture Partners publishes its 2023 Impact Report, thanking investors and advisors for their support.
- BVP 2024 Impact Report now available! ~ BVP/article/bvp-2024-impact-report
Press
6 pages- Curapath and Cristal Therapeutics Sign Co-Exclusive License of CliCr Bioconjugation Platform ~ BVP/article/curapath-and-cristal-therapeutics
Paterna, Valencia, SPAIN and Maastricht, THE NETHERLANDS – 26 November 2025
- Lely invests in Dutch scale-up Grassa ~ BVP/article/lely-invests-in-grassa
Lely and Grassa partner to advance sustainable agriculture by unlocking grass’s potential and exploring new business models for farmers.
- Matisse Pharmaceuticals & EpiDisease receive EU funding for their eHISTOCURE project ~ BVP/article/matiess-and-epidisease
Matisse Pharmaceuticals and EpiDisease receive a €524,000 Eurostars grant for their eHISTOCURE project.
- News ~ BVP/news
Team
6 pages- Carmel van den Berk joins the BVP Health team ~ BVP/article/carmel-van-den-berk-joins-the-bvp-health-team
Brightlands Venture Partners adds Carmel van den Berk as Principal to its Health team.
- Lex Westbroek ~ BVP/team/lex-westbroek
Lex focuses on early-stage companies in sustainable chemicals and materials across a broad range of industries. He is drawn to areas with real-world impact, where success depends on aligning technology with genuine industrial needs and exceptional people.
- Luc Starmans promoted to Partner in Health Team BVP ~ BVP/article/luc-starmans-promoted-to-partner-in-health-team-bvp
Geleen, The Netherlands, 9 October 2023. Brightlands Venture Partners (BVP), an impact venture capital firm based in the Netherlands, announced today the promotion of Luc Starmans, PhD, to Partner in the Health team.
- Marcel Lubben ~ BVP/team/marcel-lubben
Marcel serves as an international board member and advisor, focusing on sustainability through industrial biotech, chemistry, and climate tech.
About
3 pages- About ~ BVP/about
Brightlands Venture Partners supports founders addressing societal challenges through scalable solutions in health, agrifood, and renewable chemistry.
- SFDR disclosure ~ BVP/sfdr-disclosure
Brightlands Venture Partners classifies its funds under the Sustainable Finance Disclosure Regulation (SFDR).
- Strategy ~ BVP/strategy
Contact
1 page- Contact ~ BVP/contact
Homepage
1 page- Homepage/
Brightlands Venture Partners invests in founders building scalable companies that address societal needs.
Privacy
1 page- Cookie policy ~ BVP/cookie-policy